SIGN UPLog In
Fimecs
Fimecs
Company

Last deal

$5.1M
Local Amount - JPY 550M

Amount

Series A

Stage

28.05.2020

Date

2

all rounds

$7.6M

Total amount

General

About Company
FIMECS is a biotech company that develops protein degradation therapeutics for difficult-to-treat diseases, including cancer.

Industry

Sector :

Subsector :

Keywords :

founded date

18.01.2018

Number of employees

1-10

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company focuses on developing drugs for undruggable cancer targets by inducing the degradation of targeted proteins through natural mechanisms. FIMECS uses a proprietary drug discovery platform that integrates E3 ligase binders and RaPPIDS™ technology to discover drug candidates. The company aims to provide drugs to patients worldwide through internal and collaborative projects.
Contacts

location

Fujisawa, Kanagawa, Japan

Phone number

Website URL

https://www.fimecs.com/

Social url